Skip to main content
Premium Trial:

Request an Annual Quote

BioTrove Licenses Through-Hole Array Technology IP from Genencor

NEW YORK, Sept. 29 (GenomeWeb News) - BioTrove said today that it has licensed from Genencor International a portfolio of patents and patent filings related to nanofluidic through-hole array technology.


BioTrove said that the intellectual property would bolster its existing through-hole array technology patent portfolio with new method and device claims.  BioTrove said that the technology is used in its Living Chip platform for molecular, cell, and tissue screening and storage.


Specific terms of the licensing deal were not disclosed.



The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.